Lesson plan

Cannabinor

Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.

Back to article

Article summary

Cannabinor (PRS-211,375) is a drug which acts as a potent and selective cannabinoid CB 2 receptor agonist. It is classed as a "nonclassical" cannabinoid with a chemical structure similar to that of cannabidiol. It has a CB 2 affinity of 17.4 nM vs 5,585 nM at CB 1 , giving it over 300× selectivity for CB 2 . It showed analgesic effects in animal studies especially in models of neuropathic pain, but failed in Phase IIb human clinical trials due to lack of efficacy.

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.